What's Going On With Tonix Pharmaceuticals (TNXP) Stock?

Tonix Pharmaceuticals Holding Corp TNXP shares are trading higher by 20% to 17 cents during Monday’s session after the company announced data on the potential mpox vaccine TNX-801 in the “Using Synthetic Biology To Battle Mpox” talk at an immunology symposium at the University of Alberta.

What Happened: The presentation highlighted TNX-801, an attenuated live-virus horsepox vaccine designed to protect against mpox (formerly monkeypox).

The company says TNX-801 offers single-dose protection and improved tolerability compared to 20th-century vaccines. It more closely resembles 19th-century vaccinia vaccines, which were effective against smallpox and long-lasting.

The company emphasized that TNX-801 could be more advantageous than existing mpox vaccines like ACAM2000 and Jynneos, offering better durability, fewer side effects, and simpler storage requirements.

Tonix says preclinical studies showed TNX-801 protects animals against lethal monkeypox challenges and reduces virus shedding, suggesting it could block transmission.

Tonix is meanwhile collaborating with Bilthoven Biologics to develop GMP manufacturing processes for TNX-801.

Read Also: Apple’s iPhone 16 Launch: JPMorgan Says ‘Staggered Pricing Approach’ Could Offset Rising Chip, Memory Costs

How To Buy TNXP Stock

By now you're likely curious about how to participate in the market for Tonix Pharmaceuticals – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, TNXP has a 52-week high of $29.76 and a 52-week low of $0.13.